LETROZOLE IMPROVES PROGRESSION-FREE SURVIVAL OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER TREATED WITH PEGYLATED LIPOSOMAL DOXORUBICIN AND MAGNETOTHERMY
PLD with local MH in combination with letrozole was more effective irrespective of the PIK3CA gene status in postmenopausal aBC patients.
Authors
- Yu D Dumanskyi
- Oksana Mykolaivna Ivankova (ORCID: https://orcid.org/0000-0003-0755-3372)
- Anton Dmitrovich Loboda (ORCID: https://orcid.org/0000-0002-1866-9111)
- I. Dosenko
- O. Movchan
- I. Smolanka (Sr)
- A. Lyashenko
Institutions
- R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology (UA)
- National Cancer Institute (UA)
Publication Details
- Journal
- Experimental Oncology
- Published
- 2025-12-30
- DOI
- https://doi.org/10.15407/exp-oncology.2025.03.356
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00